Organovo Holdings, Inc. News Releases https://ir.organovo.com/ Organovo Holdings, Inc. News Releases en Organovo to Present at Raymond James Life Sciences and MedTech Conference https://ir.organovo.com/news-releases/news-release-details/organovo-present-raymond-james-life-sciences-and-medtech SAN DIEGO , June 13, 2019 (GLOBE NEWSWIRE) -- Organovo Holdings, Inc. (NASDAQ:ONVO) (“Organovo”), a biotechnology company pioneering the development of 3D bioprinted tissues aimed at treating a range of serious adult and pediatric liver diseases, today announced that Chief Executive Officer Taylor Thu, 13 Jun 2019 08:05:00 -0400 Organovo Holdings, Inc. News Releases 10946 Organovo Collaborates With MCRI and Leiden University Medical Center to Develop Stem Cell-Based Bioprinted Tissue Treatments for Kidney Disease https://ir.organovo.com/news-releases/news-release-details/organovo-collaborates-mcri-and-leiden-university-medical-center SAN DIEGO , May 30, 2019 (GLOBE NEWSWIRE) -- Organovo Holdings, Inc. (NASDAQ:ONVO) (“Organovo”), a biotechnology company pioneering the development of 3D bioprinted tissues aimed at treating a range of serious diseases, today announced a collaboration with Professor Melissa Little at the Murdoch Thu, 30 May 2019 08:05:00 -0400 Organovo Holdings, Inc. News Releases 10931 Organovo Updates Key Clinical Development Goals; Company Reports Preliminary Fiscal Fourth-Quarter 2019 Results https://ir.organovo.com/news-releases/news-release-details/organovo-updates-key-clinical-development-goals-company-reports - Pre-Investigational New Drug (“IND”) meeting with the FDA expected to be held in calendar 2020 - Submit first IND in calendar 2021 SAN DIEGO , May 22, 2019 (GLOBE NEWSWIRE) -- Organovo Holdings, Inc. (NASDAQ:ONVO) (“Organovo”), a biotechnology company pioneering the development of 3D bioprinted Wed, 22 May 2019 16:05:00 -0400 Organovo Holdings, Inc. News Releases 10916 Organovo Announces Release Date for Preliminary Fiscal Fourth-Quarter 2019 Financial Results https://ir.organovo.com/news-releases/news-release-details/organovo-announces-release-date-preliminary-fiscal-fourth SAN DIEGO , May 17, 2019 (GLOBE NEWSWIRE) -- Organovo Holdings, Inc. (NASDAQ:ONVO) (“Organovo”) will host a conference call on Wednesday, May 22, 2019 at 5:00 p.m. Eastern Time (ET) to discuss the Company's preliminary fiscal fourth-quarter 2019 operating and financial highlights.  In advance of Fri, 17 May 2019 08:05:00 -0400 Organovo Holdings, Inc. News Releases 10886 Organovo to Present at 2019 Cell & Gene Meeting on the Mediterranean https://ir.organovo.com/news-releases/news-release-details/organovo-present-2019-cell-gene-meeting-mediterranean SAN DIEGO , April 17, 2019 (GLOBE NEWSWIRE) -- Organovo Holdings, Inc. (NASDAQ:ONVO) (“Organovo”), a biotechnology company pioneering the development of 3D bioprinted tissues aimed at treating a range of serious adult and pediatric liver diseases, today announced that Chief Medical Officer, Dr. Wed, 17 Apr 2019 08:05:00 -0400 Organovo Holdings, Inc. News Releases 10871 Organovo to Participate in Nash Panel Discussion at 31st Annual Roth Conference https://ir.organovo.com/news-releases/news-release-details/organovo-participate-nash-panel-discussion-31st-annual-roth SAN DIEGO , March 14, 2019 (GLOBE NEWSWIRE) -- Organovo Holdings, Inc. (NASDAQ:ONVO) (“Organovo”) today announced that it will participate in a panel at the 31 st  Annual ROTH Conference, being held in Laguna Niguel, Ca. from March 17-19, 2019.  The Company will also participate in one-on-one Thu, 14 Mar 2019 08:05:00 -0400 Organovo Holdings, Inc. News Releases 10861 Organovo Appoints New Board Member https://ir.organovo.com/news-releases/news-release-details/organovo-appoints-new-board-member-0 SAN DIEGO , Feb. 20, 2019 (GLOBE NEWSWIRE) -- Organovo Holdings, Inc. (NASDAQ:ONVO) (“Organovo”), a biotechnology company pioneering the development of 3D bioprinted tissues aimed at treating a range of serious adult and pediatric liver diseases, today announced that its board of directors has Wed, 20 Feb 2019 08:05:54 -0500 Organovo Holdings, Inc. News Releases 10686 Organovo Affirms Key Clinical Development Goals; Company Reports Fiscal Third-Quarter 2019 Results https://ir.organovo.com/news-releases/news-release-details/organovo-affirms-key-clinical-development-goals-company-0 Pre-Investigational New Drug (“IND”) meeting with the FDA expected to be held in calendar 2019 Submit first IND in calendar 2020 SAN DIEGO , Feb. 07, 2019 (GLOBE NEWSWIRE) -- Organovo Holdings, Inc. (NASDAQ:ONVO) (“Organovo”), a biotechnology company pioneering the development of 3D bioprinted Thu, 07 Feb 2019 16:05:49 -0500 Organovo Holdings, Inc. News Releases 10681 Organovo Announces Release Date for Fiscal Third-Quarter 2019 Financial Results https://ir.organovo.com/news-releases/news-release-details/organovo-announces-release-date-fiscal-third-quarter-2019 SAN DIEGO , Jan. 17, 2019 (GLOBE NEWSWIRE) -- Organovo Holdings, Inc. (NASDAQ:ONVO) (“Organovo”) will host a conference call on Thursday, February 7, 2019 at 5:00 p.m. Eastern Time (ET) to discuss the Company's fiscal third-quarter 2019 operating and financial highlights.  In advance of the call on Thu, 17 Jan 2019 08:05:50 -0500 Organovo Holdings, Inc. News Releases 10676 Organovo Appoints New Board Member https://ir.organovo.com/news-releases/news-release-details/organovo-appoints-new-board-member SAN DIEGO , Dec. 06, 2018 (GLOBE NEWSWIRE) -- Organovo Holdings, Inc. (NASDAQ:ONVO) (“Organovo”), a biotechnology company pioneering the development of 3D bioprinted tissues aimed at treating a range of serious adult and pediatric liver diseases, today announced that its board of directors has Thu, 06 Dec 2018 08:05:33 -0500 Organovo Holdings, Inc. News Releases 10671